North America Veterinary Vaccines Market 2022-2028

2.1. Impact of Covid-19 on the Veterinary Vaccines Market
2.2. Key Insights
2.2.1. Increasing Innovation by Market Participants
2.2.2. Advancements in Vaccine and Diagnostic Technology
2.3. Porter's Five Forces Analysis
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitutes
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Threat of Competitive Rivalry
2.4. Market Attractiveness Index
2.5. Value Chain Analysis
2.6. Key Buying Criteria
2.7. Regulatory Framework
2.8. Vendor Scorecard
2.9. Key Market Strategies
2.9.1. Mergers & Acquisitions
2.9.2. Contracts & Agreements
2.9.3. Product Launches
2.9.4. Expansions & Divestitures
2.10. Market Drivers
2.10.1. High Vaccine Demand Due to Increasing Animal Population and Diseases
2.10.2. Government-Organized Vaccination Drives
2.10.3. Advanced Vaccine Research and Development
2.11. Market Challenges
2.11.1. Lack of Awareness and Scarcity of Skilled Veterinarians
2.11.2. Stringent Rules and Regulations Pertaining to Vaccine Use
2.12. Market Opportunities
2.12.1. Growing Use of Vaccines in the American Market
2.12.2. Rising Demand for Companion Animals

3.1. Livestock Animals
3.1.1. Cattle
3.1.2. Pigs
3.1.3. Poultry
3.1.4. Sheep
3.1.5. Other Livestock Animals
3.2. Companion Animals
3.2.1. Canine
3.2.2. Feline
3.2.3. Equine
3.3. Aquaculture

4.1. Canine Disease
4.2. Porcine Disease
4.3. Bovine Disease
4.4. Poultry Disease
4.5. Aquaculture Disease
4.6. Other Disease Types

5.1. Attenuated Vaccines
5.2. Inactivated Vaccines
5.3. Toxoid Vaccines
5.4. Conjugate Vaccines
5.5. Dna Vaccines
5.6. Recombinant Vaccines
5.7. Subunit Vaccines

6.1. United States
6.2. Canada

7.1. Boehringer Ingelheim International GmbH
7.2. Brilliant Bio Pharma
7.3. Ceva Sante Animale
7.4. Elanco Animal Health Inc
7.5. Hester Biosciences Ltd
7.6. Hipra
7.7. Indian Immunologicals Limited
7.8. Merck Animal Health
7.9. Phibro Animal Health
7.10. Vaxxinova GmbH
7.11. Virbac Sa
7.12. Zoetis Inc

8.1. Research Scope & Deliverables
8.2. Sources of Data
8.3. Research Methodology

Table 1: North America Veterinary Vaccines Market, by Country, 2022-2028 (In $ Million)
Table 2: Regulatory Framework
Table 3: Vendor Scorecard
Table 4: North America Veterinary Vaccines Market, by Animal Type, 2022-2028 (In $ Million)
Table 5: North America Veterinary Vaccines Market, by Livestock Animals, 2022-2028 (In $ Million)
Table 6: North America Veterinary Vaccines Market, by Companion Animals, 2022-2028 (In $ Million)
Table 7: North America Veterinary Vaccines Market, by Disease Type, 2022-2028 (In $ Million)
Table 8: North America Veterinary Vaccines Market, by Product Type, 2022-2028 (In $ Million)
Table 9: North America Veterinary Vaccines Market, by Country Outlook, 2022-2028 (In $ Million)

Figure 1: Market Attractiveness Index
Figure 2: Value Chain Analysis
Figure 3: Key Buying Criteria
Figure 4: North America Veterinary Vaccines Market, by Animal Type, 2021 & 2028 (In %)
Figure 5: North America Veterinary Vaccines Market, by Livestock Animals, 2022-2028 (In $ Million)
Figure 6: North America Veterinary Vaccines Market, by Livestock Animals, 2021 & 2028 (In %)
Figure 7: North America Veterinary Vaccines Market, by Cattle, 2022-2028 (In $ Million)
Figure 8: North America Veterinary Vaccines Market, by Pigs, 2022-2028 (In $ Million)
Figure 9: North America Veterinary Vaccines Market, by Poultry, 2022-2028 (In $ Million)
Figure 10: North America Veterinary Vaccines Market, by Sheep, 2022-2028 (In $ Million)
Figure 11: North America Veterinary Vaccines Market, by Other Livestock Animals, 2022-2028 (In $ Million)
Figure 12: North America Veterinary Vaccines Market, by Companion Animals, 2022-2028 (In $ Million)
Figure 13: North America Veterinary Vaccines Market, by Companion Animals, 2021 & 2028 (In %)
Figure 14: North America Veterinary Vaccines Market, by Canine, 2022-2028 (In $ Million)
Figure 15: North America Veterinary Vaccines Market, by Feline, 2022-2028 (In $ Million)
Figure 16: North America Veterinary Vaccines Market, by Equine, 2022-2028 (In $ Million)
Figure 17: North America Veterinary Vaccines Market, by Aquaculture, 2022-2028 (In $ Million)
Figure 18: North America Veterinary Vaccines Market, by Disease Type, 2021 & 2028 (In %)
Figure 19: North America Veterinary Vaccines Market, by Canine Disease, 2022-2028 (In $ Million)
Figure 20: North America Veterinary Vaccines Market, by Porcine Disease, 2022-2028 (In $ Million)
Figure 21: North America Veterinary Vaccines Market, by Bovine Disease, 2022-2028 (In $ Million)
Figure 22: North America Veterinary Vaccines Market, by Poultry Disease, 2022-2028 (In $ Million)
Figure 23: North America Veterinary Vaccines Market, by Aquaculture Disease, 2022-2028 (In $ Million)
Figure 24: North America Veterinary Vaccines Market, by Other Disease Type, 2022-2028 (In $ Million)
Figure 25: North America Veterinary Vaccines Market, by Product Type, 2021 & 2028 (In %)
Figure 26: North America Veterinary Vaccines Market, by Attenuated Vaccines, 2022-2028 (In $ Million)
Figure 27: North America Veterinary Vaccines Market, by Inactivated Vaccines, 2022-2028 (In $ Million)
Figure 28: North America Veterinary Vaccines Market, by Toxoid Vaccines, 2022-2028 (In $ Million)
Figure 29: North America Veterinary Vaccines Market, by Conjugate Vaccines, 2022-2028 (In $ Million)
Figure 30: North America Veterinary Vaccines Market, by Dna Vaccines, 2022-2028 (In $ Million)
Figure 31: North America Veterinary Vaccines Market, by Recombinant Vaccines, 2022-2028 (In $ Million)
Figure 32: North America Veterinary Vaccines Market, by Subunit Vaccines, 2022-2028 (In $ Million)
Figure 33: North America Veterinary Vaccines Market, Country Outlook, 2021 & 2028 (In %)
Figure 34: United States Veterinary Vaccines Market 2022-2028 (In $ Million)
Figure 35: Canada Veterinary Vaccines Market 2022-2028 (In $ Million)